Biotest AG, DE0005227235

Biotest AG, DE0005227235

12.06.2017 - 10:39:34

Biotest AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Biotest AG Landsteinerstraße 5 63303 Dreieich Germany 2. Reason for notification   Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments   Change of breakdown of voting rights X Other reason:Rejection of offer of shareholders to purchase shares outside of takeover offer as shareholders will tender shares into public takeover offer 3. Details of person subject to the notification obligation Name: City and country of registered office: Mr Yuewen Zheng 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.  5. Date on which threshold was crossed or reached 09 Jun 2017 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer Resulting situation 0 % 0 % 0 % 19785726 Previous notification 0 % 15.17 % 15.17 % / 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in %   direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) direct (Sec. 21 WpHG) indirect (Sec. 22 WpHG) % % Total % b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligation  Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least held 3% or more) % of voting rights through instruments (if at least held 5% or more) Total of both (if at least held 5% or more) Yuwen Zheng % % % Creat Group Co., Ltd. % % % Creat Tiancheng Investment Holdings Co., Ltd. % % % Tiancheng Fortune Management Limited % % % Tiancheng International Investment Limited % % % Tiancheng (Germany) Pharmaceutical Holdings AG % % % 9. In case of proxy voting according to Sec. 22 para. 3 WpHGDate of general meeting: Holding position after general meeting: % (equals voting rights) 10. Other explanatory remarks: 

12.06.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English

Company: Biotest AG Landsteinerstraße 5 63303 Dreieich

Germany Internet: http://www.biotest.de   End of News DGAP News Service

582003  12.06.2017 

@ dgap.de